(Press-News.org) Young people who use multiple muscle-building supplements are more likely to report symptoms of muscle dysmorphia, per Canadian study of more than 2,500 adolescents and young adults.
####
Article URL: https://plos.io/3EyuhD6
Article Title: Muscle-building supplement use is associated with muscle dysmorphia symptomatology among Canadian adolescents and young adults
Author Countries: Canada, France, U.S.
Funding: This study was funded by the Connaught New Researcher Award (#512586; KTG) at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
END
Young people who use multiple muscle-building supplements are more likely to report symptoms of muscle dysmorphia
2025-02-19
ELSE PRESS RELEASES FROM THIS DATE:
A miniature swimming robot inspired by marine flatworms
2025-02-19
Swimming robots play a crucial role in mapping pollution, studying aquatic ecosystems, and monitoring water quality in sensitive areas such as coral reefs or lake shores. However, many devices rely on noisy propellers, which can disturb or harm wildlife. The natural clutter in these environments – including plants, animals, and debris – also poses a challenge to robotic swimmers.
Now, researchers in the Soft Transducers Lab and the Unsteady flow diagnostics laboratory in EPFL’s School of Engineering, and at the Max Planck Institute for Intelligent Systems, have developed ...
Natural hydrogen: a sustainable energy source in mountain ranges
2025-02-19
The successful development of sustainable georesources for the energy transition is a key challenge for humankind in the 21st century. Hydrogen gas (H2) has great potential to replace current fossil fuels while simultaneously eliminating the associated emission of CO2 and other pollutants. However, a major obstacle is that H2 must be produced first. Current synthetic hydrogen production is at best based on renewable energies but it can also be polluting if fossil energy is used.
The solution may be found ...
Scientists identify a new cancer immunotherapy target: Dysfunctional B cells
2025-02-19
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood – known as the tertiary lymphoid structure – where they become frustratingly dysfunctional when in close contact with tumors.
Described today in the journal Science Translational Medicine, the finding gives oncologists a new target for developing immunotherapies: double negative memory B cells, so-called because they are negative for two markers found on the surface of their more common brethren. They may also be a useful diagnostic ...
New Australian dinosaurs and the oldest megaraptorid fossils in the world
2025-02-19
Groundbreaking research published today in the Journal of Vertebrate Paleontology has unveiled a landmark discovery – fossils of the world’s oldest known megaraptorid and the first evidence of carcharodontosaurs in Australia. These finds rewrite the evolutionary history of theropod dinosaurs, uncovering a predator hierarchy unique to Cretaceous Australia.
The research, led by Museums Victoria Research Institute and Monash University PhD student Jake Kotevski, describes five theropod fossils discovered along Victoria’s coastline. The fossils were unearthed in the upper Strzelecki Group (Bunurong/Boonwurrung ...
EMBARGOED: Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements
2025-02-19
Study Title: Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
Publication: Science Translational Medicine
Dana-Farber Cancer Institute authors: Veronica Rendo, PhD, Eudocia Q. Lee, MD, MPH, Veronica Rendo, PhD Patrick Y. Wen, MD, Keith L. Ligon, MD, PhD, Rameen Beroukhim, MD, PhD
Summary: Clinical research by Dana-Farber scientists suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy. Navtemadlin ...
Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber
2025-02-19
Boston - Kimberly Stegmaier, MD, was named Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital, in an announcement made today. Her appointment is effective April 1, 2025.
Stegmaier, a Dana-Farber, Boston Children’s Hospital, and Harvard Medical School faculty member since 2002, Stegmaier is currently Vice Chair for Pediatric Oncology Research at Dana-Farber, Co-Director of the Pediatric Hematologic Malignancy Program at Dana-Farber and Boston Children’s Hospital, Co-Leader for the Dana-Farber/Harvard Cancer Center Leukemia Program, and a Professor ...
Human Immunome Project and Michelson Medical Research Foundation award $150,000 grants to three early-career scientists researching immunology and vaccines
2025-02-19
NEW YORK – The Human Immunome Project (HIP) and Michelson Medical Research Foundation (MMRF) have awarded Dr. Omar Abudayyeh (Brigham and Women’s Hospital; Harvard Medical School), Dr. Caleb Lareau (Memorial Sloan Kettering Cancer Center), and Dr. Yuzhong Liu (Scripps Research) the 2024 Michelson Prizes: Next Generation Grants.
The $150,000 research grants are awarded annually to support early-career scientists advancing human immunology, vaccine discovery, and immunotherapy research for major global diseases.
“Investing in bold, early-career scientists fuels the high-risk, high-reward ideas ...
Devastating storms define Appalachia’s 2024 climate
2025-02-19
After a year of weather extremes that brought everything from deadly floods to bitter cold, experts at East Tennessee State University have released a detailed analysis of the region’s 2024 weather patterns.
Their findings highlight both record-breaking temperatures and catastrophic storms – underscoring the growing need for preparedness as communities face unpredictable conditions.
The report, published by Tennessee’s Climate Office housed at ETSU, details how Southern Appalachia endured scorching heat and devastating floods, including the tragic September storm linked to ...
CRISPR manipulates plants’ flower powers
2025-02-19
Humans have appreciated the beauty of flowers for centuries. Yet, flowers aren’t just aesthetically pleasing. They also play a crucial role in plant reproduction. In all plants, a well-studied gene with a curious name, Unusual Floral Organs (UFO), orchestrates the flowering process. UFO expression hinges on another complex process called cis-regulation. And this one has remained a “black box” of plant biology research for years.
Now, using CRISPR gene editing, Cold ...
Text message tool addresses “time toxicity” for cancer patients
2025-02-19
PHILADELPHIA – Cancer patients spend a lot of time on their care. Meeting with doctors and other members of their health care team, getting labs and other tests, picking up prescriptions, and undergoing treatment all takes time. So does getting to and from each appointment, sitting in the waiting room between each appointment, and so on.
In recent years, cancer researchers have worked to quantify the level of “time toxicity” or time spent commuting to, waiting for, and receiving cancer treatment. Now, for the first time, a pilot study has shown it’s possible to use digital technology to safely ...